Pharmaceutical phenylquinoline and chromen-2-one triazole compounds
US7960409B2 · kind B2 · utility
7Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 1, 2008 |
| Grant date | Jun 14, 2011 |
| Priority date | — |
| Expiry date | Jan 13, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The instant invention provides compounds of Formula I which are leukotriene biosynthesis inhibitors.Compounds of Formula I are useful as anti-atherosclerotic, anti-asthmatic, anti-allergic, anti-inflammatory and cytoprotective agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.